ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024
DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus.
Yujian Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.